Seattle Genetics News

On June 18th, Seattle Genetics announced it had received a milestone payment from Genentech after the latter filed an IND application for an antibody-drug conjugate [ADC] powered by Seattle Genetics' ...

Shares of the Boeing Co. slid to a three-year low Thursday amid concerns over high oil prices and a possible strike at the company's commercial airplane business.

Seattle Genetics Inc. Q2 2008 Earnings Call July 22, 2008 5:00 pm ET Executives Peggy Pinkston - Director of Corporate Communications Clay Siegall - President and CEO Todd Simpson - CFO Analysts Mark Monane - ...

Seattle-based SeaBright Insurance Holdings said net income for the quarter fell to $6.4 million, or 30 cents a share, compared with $10.2 million, or 49 cents a share, during the same period a year earlier.

CalAmp Corp. , a leading provider of wireless products, services and solutions, today announced the introduction of the Aercept 1400S - 07/22/2008 - 04:16 PM Allstate Announces Quarterly Dividend NORTHBROOK, ...

Seattle Genetics Inc. Q2 2008 Earnings Call July 22, 2008 5:00 pm ET Executives Peggy Pinkston - Director of Corporate Communications Clay Siegall - President and CEO Todd Simpson - CFO Analysts Mark Monane - ...

Few things are better in biotech than holding the rights to a sought-after technology.

For my story today on Seattle Genetics' deal with Daiichi Sankyo I talked to Seattle Genetics CEO Clay Siegall.

Seattle Genetics has entered into an exclusive, worldwide collaboration agreement with Daiichi Sankyo for the development of antibody-drug conjugates targeting a single antigen found on multiple types of solid ...

IT process automation seeks to radically reduce the costs and increase the reliable execution of repetitive tasks that underpin the delivery of business services.

VLST Corp., the heavily funded but under-the-radar Seattle-based biotech company, has hired a top executive from Seattle Genetics to be its chief scientific officer.

The Seattle Chapter of the National Investor Relations Institute announced today that Weyerhaeuser ' s 2007 annual report won " Best of Show " at the 2008 Investor Communications Awards Gala held June 26.

Who are the most influential figures in the local biotech industry here? Over the last week, I've posed that question to the CEOs of Seattle Genetics , Trubion Pharmaceuticals , Targeted Genetics , the ...

In December 2006, Seattle Genetics reported preliminary data from a phase one study of the company's SGN-40 treatment in patients with non-Hodgkin lymphoma.

June 6, 2008 - Seattle Genetics, Inc. today announced that SGN-35 will be highlighted in an oral presentation during a plenary session on Saturday, June 7, 2008 at the International Conference on Malignant ...

Seattle Genetics, Inc. today announced final data from the phase I clinical trial of SGN-40 in patients with relapsed or refractory non-Hodgkin lymphoma.

Main Category: Lymphoma / Leukemia Also Included In: Cancer / Oncology ; Clinical Trials / Drug Trials Article Date: 05 Jun 2008 - 2:00 PDT Seattle Genetics, Inc.

Seattle Genetics posts data from cancer treatment trial At the American Society of Clinical Oncology meeting Tuesday, Seattle Genetics posted data from an ongoing trial of its SGN-35 cancer treatment.

This year's ASCO annual meeting should be a very exciting event for anyone who has been following the field of antibody-drug conjugates [ADCs]. During the conference, investigators will present impressive ...

“If I had $100 million in 1979, my wife would not have let me spend it on disk storage”

COFFEE AND INTERNET: Internet pioneer Vint Cerf told about 800 people at the Technology Alliance's annual luncheon Friday about the early days of the Internet, the promise of government-funded broadband ... via Seattle Post-Intelligencer